⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL27585465 | 0.97 | ACHE (0.42) | — | |
| SCHEMBL8037218 | 0.81 | — | — | |
| Water SCHEMBL27636466 | 0.79 | HDAC1 (0.44) | — | |
| SCHEMBL12260883 | 0.79 | HTR2A (0.43) | — | |
| SCHEMBL9269096 | 0.77 | — | — | |
| SCHEMBL23552935 | 0.74 | — | — | |
| SCHEMBL168684 | 0.74 | — | — | |
| SCHEMBL29370717 | 0.74 | — | — | |
| SCHEMBL91411 | 0.74 | — | — | |
| SCHEMBL2625448 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11793064-B2 | Organic metal complex, and organic light emitting device and display apparatus using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-10-17 | — | — | US | disclosed |
| US-11342514-B2 | Organic metal complex, and organic light emitting device and display apparatus using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2022-05-24 | — | — | US | disclosed |
| EP-3228302-B1 | HAIR DEFORMATION TREATMENT AGENT | KAO CORP (JP) | 2020-09-02 | — | — | EP | disclosed |
| US-20200259106-A1 | ORGANIC METAL COMPLEX, AND ORGANIC LIGHT EMITTING DEVICE AND DISPLAY APPARATUS USING THE SAME | SAMSUNG ELECTRONICS CO LTD (KR) | 2020-08-13 | — | — | US | disclosed |
| US-20190348618-A1 | ORGANIC METAL COMPLEX, AND ORGANIC LIGHT EMITTING DEVICE AND DISPLAY APPARATUS USING THE SAME | SAMSUNG ELECTRONICS CO LTD (KR) | 2019-11-14 | — | — | US | disclosed |
| US-10367156-B2 | Organic metal complex, and organic light emitting device and display apparatus using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-07-30 | — | — | US | disclosed |
| EP-3228302-A1 | HAIR DEFORMATION TREATMENT AGENT | Kao Corporation (JP) | 2017-10-11 | — | — | EP | disclosed |
| EP-3228300-A1 | HAIR DEFORMATION TREATMENT AGENT | Kao Corporation (JP) | 2017-10-11 | — | — | EP | disclosed |
| WO-2016184652-A9 | METHODS FOR PRODUCING METALATED ORGANIC COMPOUNDS | LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) | 2017-08-10 | — | — | WO | disclosed |
| US-20170092882-A1 | ORGANIC METAL COMPLEX, AND ORGANIC LIGHT EMITTING DEVICE AND DISPLAY APPARATUS USING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-03-30 | — | — | US | disclosed |
| US-9554442-B2 | Organic metal complex, and organic light emitting device and display apparatus using the same | CANON KABUSHIKI KAISHA (JP) | 2017-01-24 | — | — | US | disclosed |
| EP-2588451-B1 | PIPERIDINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS | BOEHRINGER INGELHEIM INT (DE) | 2015-12-30 | — | — | EP | disclosed |
| WO-2015073767-A1 | SUBSTITUTED 4,5,6,7-TETRAHYDROPYRAZOLO[1,5-A]PYRAZINE DERIVATIVES AS CASEIN KINASE 1 D/E INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2015-05-21 | — | — | WO | disclosed |
| WO-2014201206-A1 | BICYCLIC SULFONAMIDE COMPOUNDS AS SODIUM CHANNEL INHIBITORS | AMGEN INC. (US) | 2014-12-18 | — | — | WO | disclosed |
| WO-2014089904-A1 | TRIAZINONE COMPOUNDS | ABBVIE INC. (US) | 2014-06-19 | — | — | WO | disclosed |
| EP-1966166-B1 | 1,2,4-TRIAZOL-l-YL BISPHENYL DERIVATIVES FOR USE IN THE TREATMENT OF ENDOCRINE-DEPENDENT TUMOURS | STERIX LTD (GB) | 2013-01-23 | — | — | EP | disclosed |
| EP-1603888-B1 | 2-(3-PHENYL-2-PIPERAZINYL-3,4-DIHYDROQUINAZOLINE-4-YL) ACETIC ACIDS AS ANTI-VIRAL AGENTS, ESPECIALLY AGAINST CYTOMEGALO VIRUSES | BAYER SCHERING PHARMA AG (DE) | 2011-01-12 | — | — | EP | disclosed |
| US-20080221127-A1 | peroxisome proliferator-activated receptor agonists; congestive heart failure, atherosclerosis, arteriosclerosis, obesity, hyperlipidemia, hypoalphalipoproteinemia, Syndrome X, diabetes, insulin resistance | PLEXXIKON INC | 2008-09-11 | — | — | US | disclosed |
| EP-1626976-B1 | OLEFIN POLYMERIZATION CATALYST SYSTEM | EXXONMOBIL CHEM PATENTS INC (US) | 2007-10-17 | — | — | EP | disclosed |